[Thrombocyte function in vitro using the Fenwal CS-3000 and Haemonetics V50 cell separators]. Kretschmer V, Ulrich W, Grass H, Heinrich D. Beitr Infusionther Klin Ernahr. 1986;15:82-92. PMID: 3753416
Fresh frozen plasma: indications and risks. National Institutes of Health Consensus Development Conference Statement. Natl Inst Health Consens Dev Conf Consens Statement. 1984;5(5):4 p.. PMID: 6395009
Platelet Symposium: Recent developments in British Blood Transfusion Service and clinical practice. Proceedings. London, 8 April 1992. Blood Coagul Fibrinolysis. 1992 Oct;3(5):615-62. PMID: 1450326
Practice Guidelines for blood component therapy: A report by the American Society of Anesthesiologists Task Force on Blood Component Therapy. Anesthesiology. 1996 Mar;84(3):732-47. PMID: 8659805
[Residual risk of infections transmitted by blood component transfusion]. Couroucé AM. Rev Epidemiol Sante Publique. 1994;42(5):463-6. PMID: 7973006
Clinical, immunologic, and technical factors affecting recovery of platelet count after platelet transfusion. Inverardi D, Bocchio C, Rossi L, Mazzucco L, De Paoli L, Borzini P. Haematologica. 2002 Aug;87(8):893-4. PMID: 12161372
Consensus conference on platelet transfusion. Royal College of Physicians of Edinburgh, UK. Clin Oncol (R Coll Radiol). 1998;10(2):135-6. PMID: 9610905
Blood still kills: six strategies to further reduce allogeneic blood transfusion-related mortality. Vamvakas EC, Blajchman MA. Transfus Med Rev. 2010 Apr;24(2):77-124. doi: 10.1016/j.tmrv.2009.11.001. PMID: 20303034
Historical perspective and future directions in platelet research. Coller BS. J Thromb Haemost. 2011 Jul;9:374-95. doi: 10.1111/j.1538-7836.2011.04356.x. PMID: 21781274
Delayed gastric emptying in critical illness: is enhanced enterogastric inhibition with cholecystokinin and peptide YY involved?. Samis AJ. Crit Care Med. 2008 May;36(5):1655-6. doi: 10.1097/CCM.0b013e318170157b. PMID: 18448925
